Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HMA+DLI vs DLI Preemptive Therapy for MRD+ Acute Leukemia Post-Transplant
NCT03662087Phase 3Unknown
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Oct 2018
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of decitabine in acute leukemia, sponsored by Nanfang Hospital, Southern Medical University. Status: unknown.
02
Drugs
decitabine
03
Conditions
acute leukemia
Beyond the preview
Go deeper on NCT03662087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03662087.